These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35240713)
1. [Advantages of Universal Early Childhood Screening for Familial Hypercholesterolaemia in Germany]. Paetow U; Kordonouri O; Schwab KO Klin Padiatr; 2023 Jan; 235(1):5-12. PubMed ID: 35240713 [TBL] [Abstract][Full Text] [Related]
2. Universal screening of children for familial hypercholesterolaemia: Value for money? Ademi Z; Martin AC Atherosclerosis; 2018 Aug; 275():384-386. PubMed ID: 29961599 [No Abstract] [Full Text] [Related]
3. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia. Wald DS; Wald NJ J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009 [TBL] [Abstract][Full Text] [Related]
4. Mutation screening in patients for familial hypercholesterolaemia (ADH). Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101 [No Abstract] [Full Text] [Related]
5. The UK National Screening Committee's position on child-parent screening for familial hypercholesterolaemia. Wald DS; Neely D J Med Screen; 2021 Sep; 28(3):217-220. PubMed ID: 34292841 [No Abstract] [Full Text] [Related]
6. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies. Martin AC; Bell DA; Brett T; Watts GF Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524 [TBL] [Abstract][Full Text] [Related]
7. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review. Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075 [TBL] [Abstract][Full Text] [Related]
8. Importance of early recognition of heterozygous familial hypercholesterolaemia. Ryan A; Byrne CD Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611 [TBL] [Abstract][Full Text] [Related]
9. Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractive. Kastelein JJ BMJ; 2000 Dec; 321(7275):1483-4. PubMed ID: 11118161 [No Abstract] [Full Text] [Related]
10. Decision to reject screening for familial hypercholesterolaemia is flawed. Wald DS; Martin AC Arch Dis Child; 2021 Jun; 106(6):525-526. PubMed ID: 32601084 [No Abstract] [Full Text] [Related]
17. Screening for familial hypercholesterolemia: what is the most effective strategy? Daniels SR Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381 [No Abstract] [Full Text] [Related]
18. Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in Australia. Martin AC; Hooper AJ; Norman R; Nguyen LT; Burnett JR; Bell DA; Brett T; Garton-Smith J; Pang J; Nowak KJ; Watts GF J Paediatr Child Health; 2022 Feb; 58(2):281-287. PubMed ID: 34387892 [TBL] [Abstract][Full Text] [Related]
19. Genetic screening for familial hypercholesterolaemia in Hong Kong. Tan K; Cheung CL; Yeung CY; Siu D; Leung J; Pang HK Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):7-10. PubMed ID: 29937437 [No Abstract] [Full Text] [Related]
20. Improving the identification of patients with a genetic diagnosis of familial hypercholesterolaemia in primary care: A strategy to achieve the NHS long term plan. Ingoe L; Potter A; Musson S; Neely D; Pilkington G; Allen AJ; Reay D; Luvai A; McAnulty C; Camm N; Berry I; Nichols J; Forbes G; Newton J; Carey PE Atherosclerosis; 2021 May; 325():38-45. PubMed ID: 33892327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]